Escient Pharmaceuticals
ID: 5331522Escient Pharmaceuticals is a GPCR-targeted Drugs founded in 2018.
4
Funding Rounds
$312.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Escient Pharmaceuticals has raised a total of $120m in funding over 4 rounds.
Key Insights:
- Escient Pharmaceuticals - Series C round, November 2022: $120m
- Escient Pharmaceuticals Inc funding round, August 2020: $75m
- Escient Pharmaceuticals Series B round September 2020: $77.5m
- Escient Pharmaceuticals funding round, May 2018: $40m
Industries
Escient Pharmaceuticals is active in the following industries: